XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 5,788 $ 1,718
Accounts receivable, net of allowances of $132 in 2023 and $114 in 2022 2,512 2,571
Inventories 2,873 2,679
Prepaid expenses and other current assets 861 857
Current assets of discontinued operations 0 186
Total current assets 12,034 8,011
Property, plant and equipment, net 4,278 4,695
Goodwill 6,407 6,452
Other intangible assets, net 6,230 6,793
Operating lease right-of-use assets 519 541
Other non-current assets 1,188 1,109
Non-current assets of discontinued operations 0 686
Total assets 30,656 28,287 Close
Current liabilities:    
Short-term debt 514 299
Current maturities of long-term debt and finance lease obligations 1,912 1,105
Accounts payable 1,246 1,110
Accrued expenses and other current liabilities 2,537 2,170
Current liabilities of discontinued operations 0 61
Total current liabilities 6,209 4,745
Long-term debt and finance lease obligations, less current portion 14,067 15,232
Operating lease liabilities 436 447
Other non-current liabilities 1,778 1,848
Non-current liabilities of discontinued operations 0 120
Total liabilities 22,490 22,392 Close
Commitments and contingencies
Equity:    
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2023 and 2022 683 683
Common stock in treasury, at cost, 176,198,622 shares in 2023 and 179,062,594 shares in 2022 (11,249) (11,389)
Additional contributed capital 6,368 6,322
Retained earnings 16,015 14,050
Accumulated other comprehensive income (loss) (3,716) (3,833)
Total Baxter stockholders’ equity 8,101 5,833
Noncontrolling interests 65 62
Total equity 8,166 5,895 Close
Total liabilities and equity $ 30,656 $ 28,287